An interventional study of Arm A and Arm B in Patient-reported Outcomes, sponsored by NYU Langone Health. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2022-10-10.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Health services research
The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patient-reported health outcomes.
NYU Langone Health is the lead sponsor of 1,421 studies on the registry; 254 are open to participants now.
Of its 231 completed or terminated interventional studies of FDA-regulated products, 195 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group will receive one version (out of two) of instructions for completing the Health Assessment Questionnaire.
Other: Arm A
Participants in this group will receive another version (out of two) of instructions for completing the Health Assessment Questionnaire.
Other: Arm B
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants in this group will receive one version (out of two) of instructions for completing the Health Assessment Questionnaire.
Intervention includes various iterations of instructions for completing the Health Assessment Questionnaire. Participants in this group will receive another version (out of two) of instructions for completing the Health Assessment Questionnaire.
Questionnaire Completion Rate (number of times patients complete or partially complete the questionnaire).
Completion rate data is routinely collected by the medical center.
Time frame: Duration of the study, up to 6 months.
This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.